Acute myeloid leukemia (AML) is a heterogeneous group of leukemias that result from clonal transformation of hematopoietic precursors through the acquisition of chromosomal rearrangements and multiple gene mutations. As a result of highly collaborative clinical research by pediatric cooperative cancer groups worldwide, disease-free survival has improved significantly during the past 3 decades. Further improvements in outcomes of children who have AML probably will reflect continued progress in understanding the biology of AML and the concomitant development of new molecularly targeted agents for use in combination with conventional chemotherapy drugs.
机构:
Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA
Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USAWashington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA
Graubert, Timothy A.
Mardis, Elaine R.
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA
Washington Univ, Dept Genet, St Louis, MO 63110 USA
Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USAWashington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA
机构:
MASSACHUSETTS GEN HOSP,HARVARD MED SCH,DEPT MED,HEMATOL UNIT,BOSTON,MA 02114MASSACHUSETTS GEN HOSP,HARVARD MED SCH,DEPT MED,HEMATOL UNIT,BOSTON,MA 02114
DICATO, MA
BULLETIN DE LA SOCIETE DES SCIENCES MEDICALES DU GRAND-DUCHE DE LUXEMBOURG,
1975,
112
(02):
: 129
-
133